查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599689

電子藥局市場：依產品類型、藥物類型、類型、經營模式- 2025-2030 年全球預測

ePharmacy Market by Product (Cold & Flu, Dental, Skin Care), Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs), Type, Business model - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

據預測，2023年電子藥局市值為536.2億美元，預計到2024年將達到626.5億美元，複合年成長率為17.29%，到2030年將達到1638.4億美元。

電子藥局市場是更廣泛的數位健康生態系統的一個子集，是指促進藥品銷售和分銷的線上平台。由於網路普及率的提高和消費者對網路購物的偏好的增加，該市場正在經歷顯著成長。這一成長的主要促進因素包括人口老化、慢性病的增加以及確保安全和無縫交易的技術進步。對電子藥局的需求在於其能夠提供便利、有競爭力的價格以及輕鬆取得藥品的能力，特別是對於偏遠地區或行動不便的人。 ePharmacy的應用範圍很廣，包括非處方藥、非處方食品、膳食補充劑和個人保健產品。對於最終用途，私人消費者、醫院和診所使用電子藥局進行高效採購。

主要市場統計
基準年[2023] 536.2億美元
預測年份 [2024] 626.5億美元
預測年份 [2030] 1638.4億美元
複合年成長率（%） 17.29%

根據市場洞察，遠端醫療服務的採用和對數位平台的信任度不斷提高是推動市場成長的關鍵因素。機會包括進入藥房基礎設施低度開發的新興市場，以及擴大產品範圍以包括遠端諮詢，從而創造全面的醫療保健體驗。此外，透過資料分析擴展個人化醫療服務顯示出巨大的成長潛力。然而，市場面臨監管障礙、假藥風險以及安全付款解決方案需求等挑戰。確保資料隱私和監管合規性可能會限制進展，但也確定了創新領域。

成熟的創新研究領域包括開發強大的認證系統來打擊假藥、先進的物流解決方案以提高交付效率，以及人工智慧主導的技術來增強個人化醫療平台的交付等。市場競爭趨於激烈，監管監管也趨於激烈，需要不斷適應和創新以維持成長。公司應專注於形成策略聯盟、加強技術基礎設施和加強消費者教育，以利用電子藥房環境中的快速成長機會。

市場動態：揭示快速發展的電子藥局市場的關鍵市場洞察

供需的動態交互作用正在改變電子藥局市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 由於醫療保健領域數位技術和電子商務的快速採用，提高了可近性和靈活性
    • 全球遠距諮詢的進步推動電子藥局設施的採用
    • 全球患有慢性和急性疾病的老年人數量不斷增加
  • 市場限制因素
    • 電子藥局開發需要技術專業知識和足夠的基礎設施
  • 市場機會
    • 將人工智慧和區塊鏈技術引入電子藥房
    • 在電子藥房中引入虛擬助理
  • 市場問題
    • 對電子藥局中藥品標籤不當的擔憂
    • 駭客和網路釣魚活動的出現導致病患資料隱私和安全問題

波特五力：駕馭電子藥局市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解電子藥局市場的外部影響

外部宏觀環境因素在塑造電子藥局市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解電子藥局市場的競爭格局

對電子藥局市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：電子藥局市場供應商的績效評估

FPNV 定位矩陣是評估電子藥局市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製電子藥局市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，電子藥局市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 醫療保健領域數位技術和電子商務的快速採用提高了可近性和靈活性
      • 遠距醫療正在不斷發展，電子藥房設施正在世界各地引入。
      • 世界各地患有慢性和急性疾病的老年人數量正在增加。
    • 抑制因素
      • 電子藥局的發展需要技術專長和適當的基礎設施
    • 機會
      • 人工智慧和區塊鏈技術在電子藥房的引入
      • 在電子藥房僱用虛擬助理
    • 任務
      • 對電子藥局中藥品標籤不當的擔憂
      • 由於駭客和網路釣魚活動的出現，與病患資料隱私和安全相關的問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章電子藥局市場：依產品

  • 介紹
  • 感冒和流感
  • 牙科
  • 護膚
  • 維他命
  • 減重

第7章電子藥局市場：依藥物類型

  • 介紹
  • 非處方藥 (OTC)
  • 聯合用藥

第 8 章電子藥局市場：按類型

  • 介紹
  • 融合的
  • 獨立的

第9章電子藥局市場：依經營模式

  • 介紹
  • 直接地
  • 市場
  • 藥局

第10章美洲電子藥局市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太電子藥局市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的電子藥局市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Med-Direct Africa推出網路藥局，承諾降低價格
    • 美國Start-Ups在緬甸推出網路藥局平台
    • 越南網路藥局Medigo 籌集了超過 200 萬美元的數位醫療資金
    • Flipkart 正在洽談收購線上藥局 Pharmarama
    • 網路藥局Grinta 融資 100 萬美國開發技術平台
    • Tata 1mg 融資 4000 萬美元，由 Tata Digital主導
    • Med-Direct Africa 在奈及利亞推出網路藥局。
    • Flipkart 憑藉新的「Flipkart Health+」應用程式進入醫療領域
    • 肯亞網路藥局Start-UpsMYDAWA 獲得蓋茲基金會 120 萬美元的津貼。
    • PharmEasy 融資 3.5 億美元，成為印度首家電子藥局獨角獸
  • 戰略分析和建議

公司名單

  • Amazon.com, Inc.
  • Apex Healthcare Berhad
  • Apollo Pharmacies Ltd.
  • Aster Pharmacies Group LLC
  • BinSina Pharmacy
  • CareOnGo
  • Chemist Direct
  • CVS Health Corporation
  • De Online Drogist
  • DOCIB Group
  • Euro-pharmas
  • Express Scripts Holding Company by Cigna
  • Farmacia Internacional
  • HealthPlus Pharmacy
  • Healthxchange Pharmacy UK Ltd.
  • Life Pharmacy
  • LloydsPharmacy Ltd.
  • Lekarna WPK SRO
  • Mahendra ePharmacy Pvt. Ltd.
  • mChemist Global Pvt. Ltd.
  • Medexpresspharma by Life Wind Medicare Pvt. Ltd.
  • Medicina Pharmacy
  • MonCoinSante
  • myPOS Software Solutions（Pvt）Ltd.
  • Netmeds by Reliance Retail Ltd.
  • Newpharma by Colruyt Group
  • OneHealth Nigeria
  • OptumRx, Inc.
  • Oxford e-Pharmacy
  • Parafarmacia-online
  • Pharm24.gr
  • Pharmacynet
  • Pharmeasy by Axelia Solutions Pvt. Ltd.
  • Practo Technologies Pvt. Ltd.
  • Rowlands Pharmacy by Phoenix Group
  • Shop Apotheke Europe NV
  • Tata 1mg
  • The French Pharmacy
  • The Independent Pharmacy
  • The Kroger Co.
  • UK Meds Direct Ltd.
  • Vamida sro
  • Walgreen Co.
  • Walmart Inc.
  • Wockhardtepharmacy
  • Zur Rose Group AG
Product Code: MRR-8C74ADFBFAFB

The ePharmacy Market was valued at USD 53.62 billion in 2023, expected to reach USD 62.65 billion in 2024, and is projected to grow at a CAGR of 17.29%, to USD 163.84 billion by 2030.

The ePharmacy market, a subset of the broader digital health ecosystem, refers to online platforms that facilitate the sale and distribution of pharmaceutical products. This market has witnessed significant growth due to the rising penetration of the internet and increasing consumer preference for online shopping. Key drivers of this growth include the expanding aging population, a rise in chronic diseases, and technological advancements that ensure secure and seamless transactions. ePharmacy's necessity lies in its ability to offer convenience, competitive pricing, and accessibility to medications, especially for those in remote locations or with mobility issues. Its application is broad, encompassing prescription medications, over-the-counter drugs, health supplements, and personal care products. In terms of end-use, individual consumers, hospitals, and clinics utilize ePharmacies for efficient procurement.

KEY MARKET STATISTICS
Base Year [2023] USD 53.62 billion
Estimated Year [2024] USD 62.65 billion
Forecast Year [2030] USD 163.84 billion
CAGR (%) 17.29%

Market insights reveal that the adoption of telehealth services and a growing trust in digital platforms are critical factors enhancing market growth. Opportunities include tapping into emerging markets with underdeveloped pharmacy infrastructure and expanding product offerings to include teleconsultations, thereby creating an integrated healthcare experience. Additionally, the expansion of personalized medicine services through data analytics presents substantial growth potential. However, the market faces challenges, such as regulatory hurdles, risks of counterfeit drugs, and the need for secure payment solutions. Ensuring data privacy and regulatory compliance can limit progress but also provide areas for innovation.

Research areas ripe for innovation include the development of robust authentication systems to combat counterfeit drugs, advanced logistics solutions for more efficient delivery, and AI-driven platforms that can enhance personalized medicine offerings. The market tends to be highly competitive with significant regulatory oversight, necessitating continuous adaptation and innovation to maintain growth. Businesses should focus on forming strategic alliances, strengthening their tech infrastructure, and enhancing consumer education to capitalize on burgeoning opportunities within the ePharmacy landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving ePharmacy Market

The ePharmacy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rapid adoption of digital technologies and eCommerce in healthcare sector for better accessibility and flexibility
    • Evolution of teleconsultation across the globe leads the adoption of ePharmacy facilities
    • Growing geriatric population with chronic and acute conditions across the globe
  • Market Restraints
    • Requirement of technical expertise and adequate infrastructure for ePharmacy development
  • Market Opportunities
    • Deployment of artificial intelligence and blockchain technology in ePharmacy
    • Introduction of virtual assistance in ePharmacy
  • Market Challenges
    • Concern regarding inappropriate labeling of drugs in ePharmacy
    • Issues pertaining to patient's data privacy and security due to emergence of hacking and fishing activities

Porter's Five Forces: A Strategic Tool for Navigating the ePharmacy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the ePharmacy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the ePharmacy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the ePharmacy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the ePharmacy Market

A detailed market share analysis in the ePharmacy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the ePharmacy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the ePharmacy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the ePharmacy Market

A strategic analysis of the ePharmacy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the ePharmacy Market, highlighting leading vendors and their innovative profiles. These include Amazon.com, Inc., Apex Healthcare Berhad, Apollo Pharmacies Ltd., Aster Pharmacies Group LLC, BinSina Pharmacy, CareOnGo, Chemist Direct, CVS Health Corporation, De Online Drogist, DOCIB Group, Euro-pharmas, Express Scripts Holding Company by Cigna, Farmacia Internacional, HealthPlus Pharmacy, Healthxchange Pharmacy UK Ltd., Life Pharmacy, LloydsPharmacy Ltd., Lekarna WPK SRO, Mahendra ePharmacy Pvt. Ltd., mChemist Global Pvt. Ltd., Medexpresspharma by Life Wind Medicare Pvt. Ltd., Medicina Pharmacy, MonCoinSante, myPOS Software Solutions (Pvt) Ltd., Netmeds by Reliance Retail Ltd., Newpharma by Colruyt Group, OneHealth Nigeria, OptumRx, Inc., Oxford e-Pharmacy, Parafarmacia-online, Pharm24.gr, Pharmacynet, Pharmeasy by Axelia Solutions Pvt. Ltd., Practo Technologies Pvt. Ltd., Rowlands Pharmacy by Phoenix Group, Shop Apotheke Europe N.V., Tata 1mg, The French Pharmacy, The Independent Pharmacy, The Kroger Co., UK Meds Direct Ltd., Vamida s.r.o., Walgreen Co., Walmart Inc., Wockhardtepharmacy, and Zur Rose Group AG.

Market Segmentation & Coverage

This research report categorizes the ePharmacy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cold & Flu, Dental, Skin Care, Vitamins, and Weight Loss.
  • Based on Drug Type, market is studied across Over the Counter (OTC) Drugs and Prescription Drugs.
  • Based on Type, market is studied across Integrated and Standalone.
  • Based on Business model, market is studied across Direct, Marketplace, and Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapid adoption of digital technologies and eCommerce in healthcare sector for better accessibility and flexibility
      • 5.1.1.2. Evolution of teleconsultation across the globe leads the adoption of ePharmacy facilities
      • 5.1.1.3. Growing geriatric population with chronic and acute conditions across the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Requirement of technical expertise and adequate infrastructure for ePharmacy development
    • 5.1.3. Opportunities
      • 5.1.3.1. Deployment of artificial intelligence and blockchain technology in ePharmacy
      • 5.1.3.2. Introduction of virtual assistance in ePharmacy
    • 5.1.4. Challenges
      • 5.1.4.1. Concern regarding inappropriate labeling of drugs in ePharmacy
      • 5.1.4.2. Issues pertaining to patient's data privacy and security due to emergence of hacking and fishing activities
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. ePharmacy Market, by Product

  • 6.1. Introduction
  • 6.2. Cold & Flu
  • 6.3. Dental
  • 6.4. Skin Care
  • 6.5. Vitamins
  • 6.6. Weight Loss

7. ePharmacy Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Over the Counter (OTC) Drugs
  • 7.3. Prescription Drugs

8. ePharmacy Market, by Type

  • 8.1. Introduction
  • 8.2. Integrated
  • 8.3. Standalone

9. ePharmacy Market, by Business model

  • 9.1. Introduction
  • 9.2. Direct
  • 9.3. Marketplace
  • 9.4. Pharmacy

10. Americas ePharmacy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific ePharmacy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa ePharmacy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Med-Direct Africa Launches e-Pharmacy, Promises Price Reduction.
    • 13.3.2. US startup launches e-pharmacy platform in Myanmar.
    • 13.3.3. Vietnamese e-pharmacy Medigo raises $2M and more digital health fundings.
    • 13.3.4. Flipkart In Discussions To Acquire Online Pharmacy Pharmallama
    • 13.3.5. e-pharmacy Grinta raises US$8 mln to develop its tech platform.
    • 13.3.6. Tata 1mg raises $40 mn led by Tata Digital, becomes unicorn.
    • 13.3.7. Med-Direct Africa launches e-Pharmacy in Nigeria.
    • 13.3.8. Flipkart taps healthcare sector with brand new 'Flipkart Health+' app.
    • 13.3.9. Kenyan e-pharmacy startup MYDAWA banks $1.2m grant funding from Gates.
    • 13.3.10. PharmEasy Raises $350 Mn; Becomes India's First Epharmacy Unicorn.
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amazon.com, Inc.
  • 2. Apex Healthcare Berhad
  • 3. Apollo Pharmacies Ltd.
  • 4. Aster Pharmacies Group LLC
  • 5. BinSina Pharmacy
  • 6. CareOnGo
  • 7. Chemist Direct
  • 8. CVS Health Corporation
  • 9. De Online Drogist
  • 10. DOCIB Group
  • 11. Euro-pharmas
  • 12. Express Scripts Holding Company by Cigna
  • 13. Farmacia Internacional
  • 14. HealthPlus Pharmacy
  • 15. Healthxchange Pharmacy UK Ltd.
  • 16. Life Pharmacy
  • 17. LloydsPharmacy Ltd.
  • 18. Lekarna WPK SRO
  • 19. Mahendra ePharmacy Pvt. Ltd.
  • 20. mChemist Global Pvt. Ltd.
  • 21. Medexpresspharma by Life Wind Medicare Pvt. Ltd.
  • 22. Medicina Pharmacy
  • 23. MonCoinSante
  • 24. myPOS Software Solutions (Pvt) Ltd.
  • 25. Netmeds by Reliance Retail Ltd.
  • 26. Newpharma by Colruyt Group
  • 27. OneHealth Nigeria
  • 28. OptumRx, Inc.
  • 29. Oxford e-Pharmacy
  • 30. Parafarmacia-online
  • 31. Pharm24.gr
  • 32. Pharmacynet
  • 33. Pharmeasy by Axelia Solutions Pvt. Ltd.
  • 34. Practo Technologies Pvt. Ltd.
  • 35. Rowlands Pharmacy by Phoenix Group
  • 36. Shop Apotheke Europe N.V.
  • 37. Tata 1mg
  • 38. The French Pharmacy
  • 39. The Independent Pharmacy
  • 40. The Kroger Co.
  • 41. UK Meds Direct Ltd.
  • 42. Vamida s.r.o.
  • 43. Walgreen Co.
  • 44. Walmart Inc.
  • 45. Wockhardtepharmacy
  • 46. Zur Rose Group AG

LIST OF FIGURES

  • FIGURE 1. EPHARMACY MARKET RESEARCH PROCESS
  • FIGURE 2. EPHARMACY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPHARMACY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EPHARMACY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EPHARMACY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EPHARMACY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EPHARMACY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES EPHARMACY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES EPHARMACY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EPHARMACY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. EPHARMACY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPHARMACY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EPHARMACY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EPHARMACY MARKET DYNAMICS
  • TABLE 7. GLOBAL EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EPHARMACY MARKET SIZE, BY COLD & FLU, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPHARMACY MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EPHARMACY MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPHARMACY MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EPHARMACY MARKET SIZE, BY WEIGHT LOSS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EPHARMACY MARKET SIZE, BY OVER THE COUNTER (OTC) DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPHARMACY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPHARMACY MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EPHARMACY MARKET SIZE, BY STANDALONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EPHARMACY MARKET SIZE, BY DIRECT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPHARMACY MARKET SIZE, BY MARKETPLACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EPHARMACY MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES EPHARMACY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA EPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM EPHARMACY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM EPHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM EPHARMACY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM EPHARMACY MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 191. EPHARMACY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. EPHARMACY MARKET, FPNV POSITIONING MATRIX, 2023